Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2006
Report date:
2006

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
The study used selective agar plates containing fructose instead of glucose.
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Active enzyme protein of Glucose oxidase (EC no. 232-601-0, CAS no. 9001-37-0, EC name: Glucose oxidase, Enzyme Class no. 1.1.3.4)
Molecular formula:
Not applicable, see remarks.
IUPAC Name:
Active enzyme protein of Glucose oxidase (EC no. 232-601-0, CAS no. 9001-37-0, EC name: Glucose oxidase, Enzyme Class no. 1.1.3.4)
Constituent 2
Reference substance name:
Protein as a constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available. See remarks.
IUPAC Name:
Protein as a constituent of enzyme deriving from the fermentation or extraction process
Constituent 3
Reference substance name:
Carbohydrates constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available. See remarks.
IUPAC Name:
Carbohydrates constituent of enzyme deriving from the fermentation or extraction process
Constituent 4
Reference substance name:
Inorganic salts as a constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available. See remarks.
IUPAC Name:
Inorganic salts as a constituent of enzyme deriving from the fermentation or extraction process
Constituent 5
Reference substance name:
Lipids as a constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available. See remarks.
IUPAC Name:
Lipids as a constituent of enzyme deriving from the fermentation or extraction process
Test material form:
liquid
Details on test material:
- Substance type: UVCB
- Name of test material (as cited in study report): Glucose Oxidase
- Lot/batch No.: R-GOx-04004
- Physical state: Clear brown liquid

Method

Target gene:
Operon for synthesis of amino acid histidine
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Metabolic activation system:
S-9 mix prepared from Aroclor®-1254-induced rat livers
Test concentrations with justification for top dose:
50, 160, 500, 1600, and 5000 µg/plate. The highest dose level tested is the maximum required by the OECD Guideline 471 for materials of low toxicity.
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: saline (0.9% NaCl)
Controls
Untreated negative controls:
yes
Remarks:
sterile saline solution
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
cumene hydroperoxide
other: 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: Treat and plate method: Bacterial cultures were centrifuged at 1700 g for 10 minutes, the supernatant was discarded and the bacteria were resuspended in one third of the original volume of fresh broth. Test tubes were prepared containing the test substance solution, vehicle, or positive control solution, S-9 mix or 0.02 M phosphate buffer pH 7.4 and concentrated bacterial suspension. After incubation at 37°C for 30 minutes with gentle shaking, nutrient broth was added to each test tube and the incubation was continued for 3 hours. After incubation, the bacteria were sedimented by centrifugation, the supernatant removed and the bacteria resuspended in buffer. After another centrifugation and removal of supernatant, the bacteria were resuspended in buffer and top agar was added. The contents of each tube were mixed with a vortex mixer and spread on minimal fructose agar plates.
- Cell density at seeding (if applicable): 10E9 bacteria/mL

DURATION
- Preincubation period: 30 minutes at 30°C, nutrient broth added, incubation continued for 3 hours
- Exposure duration: plates were incubated for 72 hours at 37°C

NUMBER OF REPLICATIONS: 2 tests with 3 plates at each test point
Rationale for test conditions:
In preliminary tests with the plate incorporation method, it was observed that the histidine in the test substance was interfering with the test system, preventing adequate assessment of the test substance for mutagenic activity. Therefore, the treat and plate method was carried out to avoid the problem.
Evaluation criteria:
The tests were considered valid if the following criteria were met:
- negative and positive control data were consistent with the historical control data for the laboratory
- the positive control data showed marked increases over the concurrent negative control values
- the evaluation of the data was not restricted by loss of plates (e.g., through contamination)

The test item would have been considered to have shown evidence for mutagenic activity in the study if all the following were met:
- increases in the number of revertant colonies were observed at one or more test points
- the mean number of revertant colonies at the test point showing the largest increase was more than twice the corresponding negative control value
- there was a credible scientific explanation for the observed dose-response relationship that involved a mutagenic effect of the test item
- the increases were reproducible between replicate plates and were observed in both main tests
- the increases were statistically significant
- increases were not directly related to increased growth of the non-revertant bacteria

The test substance would be considered to have shown no evidence of mutagenic activity if no dose-related increased in the numbers of revertant colonies which exceeded 1.5 times the negative control value were observed at any test point. The test item would also be considered to have shown no evidence of mutagenic activity if moderately larger increases had been observed that were not reproducible, not statistically significant, or which were sporadic (without a scientifically valid explanation for the dose-response relationship that involved a mutagenic effect of the test substance). Increases between 1.5 and 2-fold greater than the negative control values, which met the other criteria for a positive result, would provide some evidence for a weak effect of the test substance, but would be considered to be clear evidence of mutagenic activity.
Statistics:
The numbers of revertant colonies at each treatment test point in the main tests were compared to the corresponding negative control values using the Analysis of Variance test. When this test showed statistically significant differences in the data, Dunnett's test was used to determine the statistical significance of the increases and decreases in the numbers of revertant colonies for each set of triplicate plates. The statistical analysis was performed with SAS® procedures (version 8.2) described in SAS/STAT® User's Guide, SAS OnlineDoc®, 1999, SAS Institute Inc., Cary, North Carolina 27513, USA.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
≥500 µg (without S-9); 5000 µg (with S-9)
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
≥160 µg (without S-9); ≥500 µg (with S-9)
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
5000 µg (without S-9)
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
≥1600 µg (without S-9)
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
In the preliminary test with the treat and plate method, the test substance was toxic to the test bacteria at dose levels of 500, 1600, and 5000 µg/plate without S-9 mix and at 5000 µg/plate with S-9 mix: reduced growth of the background lawn of non-revertant bacteria and reductions in the number of revertant colonies.

The results of the two main tests showed the test substance was toxic to most of the tester strains at the higher does levels, causing reduced growth of background lawn and reductions in the number of revertant colonies. These effects were generally observed over a wider range of dose levels for treatments without S-9 than for treatments with S-9 mix. The amount of toxicity showed some variation between the tester strains.

No biologically significant increases in the number of revertant colonies were observed in any tester strain after treatment with the test substance at any dose level, either in the absence or presence of S-9 mix. A small, but statistically significant increase was observed in strain TA 1535 in the first main test after treatment with the test substance at 5000 µg/plate without S-9 mix. This increase does not meet the criteria for a mutagenic effect because it was too small and it was not reproduced in the second test.

Any other information on results incl. tables

Main Test Strain TA102

Dose

Number of Revertant Colonies / Plate

Plate 1

Plate 2

Plate 3

Mean

SD

Ratio

Strain TA102, Without S-9 Mix, Main Test 1

Control

436

432

472

446.7

22.0

 

5000 µg

440T

420T

496T

452.0

39.4

1.01

1600 µg

416T

400T

576T

464.0

97.3

1.04

500 µg

416

368

500

428.0

66.8

0.96

160 µg

424

404

400

409.3

12.9

0.92

50 µg

380

420

324

374.7

48.2

0.84

Cumene hydroperoxide

100 µg

800

1152

1040

997.3

179.8

2.23

Strain TA102, Without S-9 Mix, Main Test 2

Control

648

488

432

522.7

112.1

 

5000 µg

440T

440T

304T

394.7

78.5

0.76

1600 µg

344T

536T

528T

469.3

108.6

0.90

500 µg

520

472

480

490.7

25.7

0.94

160 µg

352

480

408

413.3

64.2

0.79

50 µg

376

432

448

418.7

37.8

0.80

Cumene hydroperoxide

100 µg

1600

1408

1536

1514.7

97.8

2.90

Strain TA102, With S-9 Mix, Main Test 1

Control

408

189

400

332.3

124.2

 

5000 µg

352

304

424

360.0

60.4

1.08

1600 µg

476

396

424

432.0

40.6

1.30

500 µg

400

304

576

426.7

137.9

1.28

160 µg

384

432

400

405.3

24.4

1.22

50 µg

432

372

448

417.3

40.1

1.26

2-Aminoanthracene 4 µg

1088

992

358

812.7

396.7

2.45

Strain TA102, With S-9 Mix, Main Test 2

Control

320

360

456

378.7

69.9

 

5000 µg

544

400

392

445.3

85.5

1.18

1600 µg

376

440

408

408.0

32.0

1.08

500 µg

360

376

448

394.7

46.9

1.04

160 µg

344

440

448

410.7

57.9

1.08

50 µg

384

384

352

373.3

18.5

0.99

2-Aminoanthracene 4 µg

1344

1216

2496

1685.3

705.0

4.45

S.D. = Standard deviation

RATIO =Mean number of revertants on treated plates/mean number of revertants on vehicle control plates

* = Statistically significant at 5% level

** = Statistically significant at 1% level

Otherwise, not statistically significant at 5% level (The positive controls were not included in the statistical analysis)

T = Toxicity: reduced growth of background lawn of non-revertant bacteria

 

Main Test Strain TA100

Dose

Number of Revertant Colonies / Plate

Plate 1

Plate 2

Plate 3

Mean

SD

Ratio

Strain TA100, Without S-9 Mix, Main Test 1

Control

218

198

272

229.3

38.3

 

5000 µg

226

184

193

201.0

22.1

0.88

1600 µg

214

201

209

208.0

6.6

0.91

500 µg

173

178

200

183.7

14.4

0.80

160 µg

206

204

212

207.3

4.2

0.90

50 µg

241

218

188

215.7

26.6

0.94

Sodium azide

1 µg

1301

1220

1208

1243.0

50.6

5.42

Strain TA100, Without S-9 Mix, Main Test 2

Control

182

214

200

198.7

16.0

 

5000 µg

180T

159T

120T

153.0

30.4

0.77

1600 µg

160

154

72

128.7

49.2

0.65

500 µg

137

126

97

120.0

20.7

0.60

160 µg

136

175

131

147.3

24.1

0.74

50 µg

209

188

146

181.0

32.1

0.91

Sodium azide

1 µg

1007

1173

1138

1106.0

87.5

5.57

Strain TA100, With S-9 Mix, Main Test 1

Control

226

238

245

236.3

9.6

 

5000 µg

198

210

221

209.7

11.5

0.89

1600 µg

221

246

264

243.7

21.6

1.03

500 µg

206

222

246

224.7

20.1

0.95

160 µg

194

199

185

192.7

7.1

0.82

50 µg

233

149

209

197.0

43.3

0.83

2-Aminoanthracene 2 µg

1379

1612

1467

1486.0

117.7

6.29

Strain TA100, With S-9 Mix, Main Test 2

Control

300

238

175

237.7

62.5

 

5000 µg

184

169

167

173.3

9.3

0.73

1600 µg

179

141

185

168.3

23.9

0.71

500 µg

172

200

168

180.0

17.4

0.76

160 µg

182

172

186

180.0

7.2

0.76

50 µg

217

213

165

198.3

28.9

0.83

2-Aminoanthracene 2 µg

2013

1820

2323

2052.0

253.8

8.63

S.D. = Standard deviation

RATIO =Mean number of revertants on treated plates/mean number of revertants on vehicle control plates

* = Statistically significant at 5% level

** = Statistically significant at 1% level

Otherwise, not statistically significant at 5% level (The positive controls were not included in the statistical analysis)

T = Toxicity: reduced growth of background lawn of non-revertant bacteria

 

Main Test Strain TA98

Dose

Number of Revertant Colonies / Plate

Plate 1

Plate 2

Plate 3

Mean

SD

Ratio

Strain TA98, Without S-9 Mix, Main Test 1

Control

29

28

36

31.0

4.4

 

5000 µg

12T

23T

24T

19.7*

6.7

0.63

1600 µg

19T

27T

22T

22.7

      4.0

0.73

500 µg

31

30

22

27.7

4.9

0.89

160 µg

17

18

15

16.7**

1.5

0.54

50 µg

38

32

31

33.7

3.8

1.09

2-Nitrofluorene

1 µg

121

144

127

130.7

11.9

4.22

Strain TA98, Without S-9 Mix, Main Test 2

Control

31

23

25

26.3

4.2

 

5000 µg

23T

20T

29T

24.0

4.6

0.91

1600 µg

29T

32T

31T

30.7

1 .5

1.16

500 µg

28T

22T

25T

25.0

3.0

0.95

160 µg

16

16

29

20.3

7.5

0.77

50 µg

25

29

23

25.7

3.1

0.97

2-Nitrofluorene

1 µg

140

104

104

116.0

20.8

4.41

Strain TA98, With S-9 Mix, Main Test 1

Control

40

34

26

33.3

7.0

 

5000 µg

20T

23T

37T

26.7

9.1

0.80

1600 µg

24

20

24

22.7

2.3

0.68

500 µg

22

27

31

26.7

4.5

0.80

160 µg

27

31

27

28.3

2.3

0.85

50 µg

30

25

36

30.3

5.5

0.91

2-Aminoanthracene 2 µg

600

644

584

609.3

31.1

18.28

Strain TA98, With S-9 Mix, Main Test 2

Control

40

46

37

41.0

4.6

 

5000 µg

40T

34T

33T

35.7

3.8

0.87

1600 µg

36

36

43

38.3

4.0

0.93

500 µg

33

30

30

31.0

1.7

0.76

160 µg

31

39

26

32.0

6.6

0.78

50 µg

31

34

34

33.0

1.7

0.80

2-Aminoanthracene 2 µg

752

896

704

784.0

99.9

19.12

S.D. = Standard deviation

RATIO =Mean number of revertants on treated plates/mean number of revertants on vehicle control plates

* = Statistically significant at 5% level

** = Statistically significant at 1% level

Otherwise, not statistically significant at 5% level (The positive controls were not included in the statistical analysis)

T = Toxicity: reduced growth of background lawn of non-revertant bacteria

 

Main Test Strain TA1537

Dose

Number of Revertant Colonies / Plate

Plate 1

Plate 2

Plate 3

Mean

SD

Ratio

Strain TA1537, Without S-9 Mix, Main Test 1

Control

15

14

4

11.0

6.1

 

5000 µg

11T

8T

9T

9.3

1.5

0.85

1600 µg

13T

9T

11T

11.0

2.0

1.00

500 µg

9T

8T

8T

8.3

0.6

0.76

160 µg

11T

8T

10T

9.7

1.5

0.88

50 µg

10

11

9

10.0

1.0

0.91

9-Aminoacridine

80 µg

868

384

728

660.0

249.1

60.00

Strain TA1537, Without S-9 Mix, Main Test 2

Control

17

28

31

25.3

7.4

 

5000 µg

7T

5T

14T

8.7**

4.7

0.34

1600 µg

9T

10T

9T

9.3**

0.6

0.37

500 µg

6T

18T

10T

11.3*

6.1

0.45

160 µg

11

13

18

14.0

3.6

0.55

50 µg

11

13

20

14.7

4.7

0.58

9-Aminoacridine

80 µg

1115

1196

528

946.3

364.5

37.36

Strain TA1537, With S-9 Mix, Main Test 1

Control

14

8

11

11.0

3.0

 

5000 µg

13T

14T

9T

12.0

2.6

1.09

1600 µg

9T

8T

5T

7.3

2.1

0.67

500 µg

4T

6T

10T

6.7

3.1

0.61

160 µg

8

11

14

11.0

3.0

1.00

50 µg

10

12

15

12.3

2.5

1.12

2-Aminoanthracene 2 µg

312

304

288

301.3

12.2

27.39

Strain TA1537, With S-9 Mix, Main Test 2

Control

8

19

17

14.7

5.9

 

5000 µg

8T

10T

13T

10.3

2.5

0.70

1600 µg

8T

13T

8T

9.7

2.9

0.66

500 µg

18

17

11

15.3

3.8

1.05

160 µg

18

23

25

22.0

3.6

1.50

50 µg

10

15

18

14.3

4.0

0.98

2-Aminoanthracene 2 µg

103

93

108

101.3

7.6

6.91

S.D. = Standard deviation

RATIO =Mean number of revertants on treated plates/mean number of revertants on vehicle control plates

* = Statistically significant at 5% level

** = Statistically significant at 1% level

Otherwise, not statistically significant at 5% level (The positive controls were not included in the statistical analysis)

T = Toxicity: reduced growth of background lawn of non-revertant bacteria

 

Main Test Strain TA1535

Dose

Number of Revertant Colonies / Plate

Plate 1

Plate 2

Plate 3

Mean

SD

Ratio

Strain TA1535, Without S-9 Mix, Main Test 1

Control

16

23

21

20.0

3.6

 

5000 µg

36

33

30

33.0**

3.0

1.65

1600 µg

27

26

27

26.7

0.6

1.33

500 µg

29

18

24

23.7

5.5

1.18

160 µg

25

20

25

23.3

2.9

1.17

50 µg

22

15

18

18.3

3.5

0.92

Sodium azide

1 µg

500

352

448

433.3

75.1

21.67

Strain TA1535, Without S-9 Mix, Main Test 2

Control

15

19

25

19.7

5.0

 

5000 µg

11

14

15

13.3

2.1

0.68

1600 µg

19

25

21

21.7

3.1

1.10

500 µg

13

16

24

17.7

5.7

0.90

160 µg

17

11

13

13.7

3.1

0.69

50 µg

21

20

15

18.7

3.2

0.95

Sodium azide

1 µg

400

408

396

401.3

6.1

20.41

Strain TA1535, With S-9 Mix, Main Test 1

Control

24

34

34

30.7

5.8

 

5000 µg

31

25

31

29.0

3.5

0.95

1600 µg

31

20

27

26.0

5.6

0.85

500 µg

31

25

31

29.0

3.5

0.95

160 µg

23

29

18

23.3

5.5

0.76

50 µg

26

28

16

23.3

6.4

0.76

2-Aminoanthracene 42 µg

147

176

164

162.3

14.6

5.29

Strain TA1535, With S-9 Mix, Main Test 2

Control

24

22

25

23.7

1 .5

 

5000 µg

19

18

19

18.7

0.6

0.79

1600 µg

16

22

26

21.3

5.0

0.90

500 µg

20

25

18

21.0

3.6

0.89

160 µg

18

20

20

19.3

1 .2

0.82

50 µg

27

22

20

23.0

3.6

0.97

2-Aminoanthracene 2 µg

184

187

210

193.7

14.2

8.18

S.D. = Standard deviation

RATIO =Mean number of revertants on treated plates/mean number of revertants on vehicle control plates

* = Statistically significant at 5% level

** = Statistically significant at 1% level

Otherwise, not statistically significant at 5% level (The positive controls were not included in the statistical analysis)

T = Toxicity: reduced growth of background lawn of non-revertant bacteria

Applicant's summary and conclusion

Conclusions:
The test substance has not shown evidence of mutagenic activity with or without S-9 activation.
Executive summary:

The test substance was tested in the Ames Test using Salmonella typhimurium strains TA 102, TA 100, TA 98, TA 1537, and TA 1535. The test was performed in accordance with OECD Guideline 471. The study was performed using selective agar plates containing fructose instead of glucose (the usual sugar in this type of plate) because glucose is the substrate for the enzymatic activity of this test substance.


A preliminary study was done using the plate incorporation method, but the histidine in the test substance interfered with the test system. A second preliminary study was done with strain TA 98 and the independent two main tests were carried out with the treat and plate method to avoid this problem. The bacteria were treated with solutions of the test substance prepared in sterile saline solution (0.9% NaCl) at five dose levels in the range 50 to 5000 µg/plate. The higest dose is equivalent to 1.87 mg active enzyme protein/ kg bw or 9.71 enzyme concentrate dry matter/kg bw


All of the dose levels in this report are expressed in terms of the total protein content of the test substance (stated by the Sponsor to be 36.24 mg/mL in the solution supplied). Negative control plates were treated by the addition of sterile saline solution (200 µL/plate). The treatments were performed both with and without a metabolic activation system (S-9 mix). Triplicate plates were prepared at each test point.


A dose related amount of insoluble material was observed on the plates in some parts of the study. The test substance was toxic to most of the tester strains at the higher dose levels, causing reduced growth of the background lawn and reductions in the number of revertant colonies. These effects were generally observed over a wider range of dose levels for treatments without S-9 mix than for treatments with S-9 mix. The amount of toxicity showed variation between tester strains. No biologically significant increases in the number of revertant colonies were observed in any tester strain after treatment with the test substance at any dose level, either in absence or presence of S-9 mix. Results obtained with the negative and positive controls demonstrated the sensitivity of the tests and efficacy of the S-9 mix metabolic activation system. Based on the results obtained in this study, it is concluded that the test substance has not shown any evidence of mutagenic activity.